Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)).

HIV clinical trials

Volumn 1, Issue 2, 2000, Pages 9-16

  Floridia, M ^a   Massella, M ^a   Bucciardini, R ^a   Perucci, C A ^a   Rossi, L ^a   Tomino, C ^a   Fragola, V ^a   Ricciardulli, D ^a   Galluzzo, C M ^a   Giannini, G ^a   Pirillo, M F ^a   Andreotti, M ^a   Mirra, M ^a   Vella, S ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STATISTICS;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HOSPITALIZATION; HUMANS; INDINAVIR; MALE; MIDDLE AGED; PATIENT ADMISSION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR;

MLCS; MLOWN;

EID: 0034281313     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/6ulm-xyb7-h4xp-bhfj     Document Type: Article

References (0)